News | October 03, 2023
Aurobindo Pharma completes sale of Antibiotic business to Apitoria Pharma
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
The inspection was a cGMP Inspection and had ended with NIL observations
The company will develop and produce premixes for human nutrition applications
Eris Lifesciences enters into term loan agreement with Citi Bank
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
